{"id":"CHEMBL1087","canonicalSmiles":"Cc1cccc(C)c1NC(=O)C1CCCCN1C","inchiKey":"INWLQCZOYSRPNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPIVACAINE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["1-methyl-2',6'-pipecoloxylidide","APF-135","Carbocaine","Carboplyin dental","Dl-mepivacaine","Mepisv","Mepivacaine","Polocaine","Polocaine-Mpf","Tevacaine"],"crossReferences":{"DailyMed":["mepivacaine%20hydrochloride"],"Wikipedia":["Mepivacaine"],"drugbank":["DB00961"],"chEBI":["6759"]},"childChemblIds":["CHEMBL1200440"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_1001139","EFO_0009540","EFO_0010582","EFO_0004269","EFO_1000786","EFO_0004616","MONDO_0004001","MONDO_0005178","EFO_0003843","MONDO_0008315","EFO_0000537"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and has 3 investigational indications."}
{"id":"CHEMBL111654","canonicalSmiles":"Sc1nc2ccccc2s1","inchiKey":"YXIWHUQXZSMYRE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-MERCAPTOBENZOTHIAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Mercaptobenzothiazole","2-Mercaptobenzothioazole","Benzothiazole-2-Thiol"],"crossReferences":{"PubChem":["124891199","124891200","144207000","144213977","17389836","26747389","26753081","29215119"],"drugbank":["DB11496"],"chEBI":["34292"]},"childChemblIds":["CHEMBL3182456"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL11471","canonicalSmiles":"CC(=N)NCCC[C@H](N)C(=O)O","inchiKey":"UYZFAUAYFLEHRC-LURJTMIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-NIO","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111337","11113558"],"drugbank":["DB03305"]},"childChemblIds":["CHEMBL1256394"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1160818","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)cc1CO","inchiKey":"WEBVWKFGRVLCNS-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160818","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03846"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL117869","canonicalSmiles":"COC(=O)c1c(O)cccc1OC/C=C/c1ccc(F)c(-c2cc(C(=O)O)no2)c1","inchiKey":"QKHWJUMLYAYZFS-ONEGZZNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL117869","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02014"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1198130","canonicalSmiles":"CC[C@@H](N)C(=O)N1CCC[C@H]1C(=O)NCc1cccc(Cl)c1","inchiKey":"OTYYXGRJXJFTCD-KGLIPLIRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1198130","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06878"]},"childChemblIds":["CHEMBL596780"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200358","canonicalSmiles":"O=C([O-])Cc1ccccc1.[Na+]","inchiKey":"HZOREEUASZHZBI-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM PHENYLACETATE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-3039","Sodium phenylacetate","Sodium phenylacetic acid"],"crossReferences":{"DailyMed":["sodium%20phenylacetate"],"PubChem":["538568"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 2 investigational indications."}
{"id":"CHEMBL1200563","canonicalSmiles":"COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])c1-c1ccc(F)cc1.[Na+]","inchiKey":"GPUADMRJQVPIAS-QCVDVZFFSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CERIVASTATIN SODIUM","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1477","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Musculoskeletal toxicity"," Nephrotoxicity"],"year":2001},"tradeNames":["Baycol"],"synonyms":["BAY W 6228","BAY-W-6228","Cerivastatin sodium","Cerivastatin sodium salt"],"crossReferences":{"PubChem":["144205797","170465109","251919809","49681715"],"chEBI":["3559"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997. It was withdrawn in United States  in 2001 due to Musculoskeletal toxicity and  Nephrotoxicity."}
{"id":"CHEMBL1200581","canonicalSmiles":"CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)[O-])c1I.[Na+]","inchiKey":"ZEYOIOAKZLALAP-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DIATRIZOATE SODIUM","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201220","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hypaque","Hypaque Sodium","Md-50","Urovist sodium","Urovist sodium 300"],"synonyms":["Diatrizoate sodium","Diatrizoic acid sodium salt","Hypaque sodium 20%","Meglumine sodium amidotrizoate injection","NSC-61815","Natrii amidotrizoas","Sodium amidotrizoate","Sodium diatrizoate","Triombrine","Urographing 370"],"crossReferences":{"DailyMed":["diatrizoate%20sodium"],"PubChem":["144211756","855850"],"chEBI":["53692"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1954 and has 1 investigational indication."}
{"id":"CHEMBL1200648","canonicalSmiles":"C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1.[Br-]","inchiKey":"OYTJKRAYGYRUJK-FMCCZJBLSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ROCURONIUM BROMIDE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201244","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Esmeron","Rocuronium bromide","Zemuron"],"synonyms":["ORG 9426","ORG-9426","Rocuronium bromide"],"crossReferences":{"DailyMed":["rocuronium%20bromide"],"PubChem":["144205990"],"chEBI":["8885"]},"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["HP_0002093","HP_0003418","EFO_0009492"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 2 investigational indications."}
{"id":"CHEMBL1200734","canonicalSmiles":"CC(C)CN(C[C@@H](OP(=O)([O-])[O-])[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1.[Ca+2]","inchiKey":"PMDQGYMGQKTCSX-HQROKSDRSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSAMPRENAVIR CALCIUM","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1664","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fosamprenavir calcium","Lexiva","Telzir"],"synonyms":["Fosamprenavir calcium","Fosamprenavir calcium salt","GW 433908G","GW-433908G"],"crossReferences":{"DailyMed":["fosamprenavir%20calcium"],"PubChem":["144206185"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for immunodeficiency disease and hiv infection and has 1 investigational indication."}
{"id":"CHEMBL1200762","canonicalSmiles":"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"PLCQGRYPOISRTQ-LWCNAHDDSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAMETHASONE SODIUM PHOSPHATE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201207","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betam-ophtal","Betamethasone sodium phosphate","Betnesol","Betnesol-n","Celestone","Vistamethasone","Vistamethasone n"],"synonyms":["Betamethasone 21-phosphate disodium salt","Betamethasone disodium phosphate","Betamethasone sodium phosphate","NSC-90616"],"crossReferences":{"DailyMed":["betamethasone%20sodium%20phosphate"],"PubChem":["144212784"],"chEBI":["3078"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","HP_0030838","EFO_1000906","EFO_0001356","HP_0003418","HP_0001742","HP_0004798","EFO_1001097","HP_0006536","HP_0030833","EFO_0000676","EFO_0004616","HP_0003419","EFO_0009552","MONDO_0005178","EFO_0005752","EFO_1001434"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and has 5 approved and 5 investigational indications."}
{"id":"CHEMBL1200826","canonicalSmiles":"O=C([O-])[O-].[Li+].[Li+]","inchiKey":"XGZVUEUWXADBQD-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":true,"name":"LITHIUM CARBONATE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Camcolit 250","Camcolit 400","Eskalith","Eskalith cr","Liskonum","Lithane","Lithium carbonate","Lithobid","Lithonate","Lithotabs","Phasal"],"synonyms":["CP-15,467-61","CP-15467-61","CP-1546761","Lithium carbonate","NSC-16895"],"crossReferences":{"DailyMed":["lithium%20carbonate"],"DrugCentral":["4207"],"PubChem":["8139879"],"Wikipedia":["Lithium_carbonate"],"drugbank":["DB14509"],"chEBI":["6504"]},"linkedTargets":{"rows":["ENSG00000082701","ENSG00000105723","ENSG00000133731"],"count":3},"linkedDiseases":{"rows":["Orphanet_98755","MONDO_0005090","Orphanet_282","EFO_0000637","MONDO_0002009","EFO_0004216","EFO_1001901","HP_0000726","EFO_0003015","EFO_1001919","EFO_0004698","HP_0100543","EFO_0000289","MONDO_0002050","MONDO_0001475","EFO_0003931","Orphanet_683","MONDO_0005180","EFO_0000712","MONDO_0001657","EFO_0009854","EFO_0003761","MONDO_0015277","MONDO_0004976","MONDO_0007079","EFO_0005230","EFO_1000158","EFO_0003756","Orphanet_646","Orphanet_98757","Orphanet_98756","HP_0001919","EFO_1002017","EFO_0009963","EFO_0005407","MONDO_0008315","EFO_0002615","EFO_1001050","Orphanet_399","MONDO_0005301","EFO_0011023","EFO_0000764","MONDO_0004975","EFO_0000702","Orphanet_278"],"count":45},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and has 5 approved and 32 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201180","canonicalSmiles":"O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl.OCCN1CCCC1","inchiKey":"DCERVXIINVUMKU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DICLOFENAC EPOLAMINE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL139","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Flector","Flector Patch","Licart"],"synonyms":["Diclofenac epolamine","Diclofenac epolaminum"],"crossReferences":{"DailyMed":["diclofenac%20epolamine"],"chEBI":["48296"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0009582","MONDO_0007254","EFO_1000652","EFO_0003843"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for pain and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201519","drugType":"Unknown","blackBoxWarning":false,"name":"VITAMIN K","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Vitamin k"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 11 investigational indications."}
{"id":"CHEMBL120293","canonicalSmiles":"C=CCn1c(=O)c2[nH]c(Cc3ccc(NC(C)=O)cc3)nc2n(CCCC)c1=O","inchiKey":"XFOWZKUTPKXWIE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL120293","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03267"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1220","canonicalSmiles":"CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C","inchiKey":"HJLSLZFTEKNLFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TINIDAZOLE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fasigyn","Symplotan","Tindamax","Tinidazole","Trimonase"],"synonyms":["CP-12,574","CP-12574","Fasigin","Haisigyn","NSC-758189","Tinidazole","Tricolam","Trimonase"],"crossReferences":{"DailyMed":["tinidazole"],"PubChem":["11112651","144204137","170465196","56422390","855690"],"Wikipedia":["Tinidazole"],"drugbank":["DB00911"],"chEBI":["63627"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 5 approved and 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1222017","canonicalSmiles":"CC(=O)N[C@H]1[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](NC(C)=O)[C@H]3O)[C@H](NC(C)=O)[C@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"WZZVUHWLNMNWLW-VFCSDQTKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIACETYLCHITOTRIOSE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04194"],"chEBI":["71404"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230813","canonicalSmiles":"OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O","inchiKey":"HFHDHCJBZVLPGP-RWMJIURBSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"ALFADEX","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.-cyclodextrin","Alfadex","Alpha cyclodextrin","Alpha-cyclodextrin","Alpha-dextrin","Alpha-schardinger dextrin","Cavamax w 6 food","Cavamax w6","Celdex a 100","Cyclohexaamylose","Cyclomaltohexaose","Dexy pearl .alpha.-100","E-457","Ins no.457","Ins-457","NSC-269470","Oristar acd","Ringdex-a"],"crossReferences":{"PubChem":["144204566","144208450","144210622","17389189","26752792","49674568"],"drugbank":["DB01909"],"chEBI":["40585"]},"description":"Oligosaccharide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1232","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)Nc4cccc(C(=O)[O-])c4)C3)[C@H](C)[C@H]12.[Na+]","inchiKey":"ZXNAQFZBWUNWJM-HRXMHBOMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ERTAPENEM SODIUM","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1359","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Invanz"],"synonyms":["Ertapenem sodium","Ertapenem sodium salt","Invanz","L-749345","MK-0826","MK-826"],"crossReferences":{"DailyMed":["ertapenem%20sodium"],"chEBI":["60070"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for infection and osteomyelitis and has 4 investigational indications."}
{"id":"CHEMBL1256841","canonicalSmiles":"O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1","inchiKey":"NOIIUHRQUVNIDD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIALAMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"],"classes":["Hepatotoxicity"],"year":1974},"tradeNames":[],"synonyms":["NSC-124514","Nialamide","Niamid"],"crossReferences":{"PubChem":["11111522","11111523","144203759","170466097","50104074","56422110","85231151","855800","90341025"],"drugbank":["DB04820"]},"linkedTargets":{"rows":["ENSG00000189221","ENSG00000069535"],"count":2},"linkedDiseases":{"rows":["EFO_0003761"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for unipolar depression. It was withdrawn in United Kingdom and  United States initially in 1974 due to Hepatotoxicity."}
{"id":"CHEMBL1359","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)Nc4cccc(C(=O)O)c4)C3)[C@H](C)[C@H]12","inchiKey":"JUZNIMUFDBIJCM-ANEDZVCMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERTAPENEM","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ertapenem","Invanz"],"crossReferences":{"DailyMed":["ertapenem%20sodium"],"Wikipedia":["Ertapenem"],"drugbank":["DB00303"],"chEBI":["404903"]},"childChemblIds":["CHEMBL1232"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 3 approved and 12 investigational indications."}
{"id":"CHEMBL1361347","canonicalSmiles":"CC1CCCC(C)N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1","inchiKey":"LBXHRAWDUMTPSE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOPAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Aquex"],"synonyms":["Chlosudimeprimylum","Clopamide","DT-327"],"crossReferences":{"PubChem":["14743456","26750017","50086820"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL139","canonicalSmiles":"O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl","inchiKey":"DCOPUUMXTXDBNB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DICLOFENAC","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cambia","Voltaren","Voltaren Ophthalmic","Voltaren Xr","Zorvolex","Zorvolex capsules"],"synonyms":["Arthrotec","Cataflam","Diclofenac","Diclofenac free acid","LAS-41007","LAS41007","Las41007","Solaraze","Voltaren","Voltaren-XR"],"crossReferences":{"DailyMed":["diclofenac","diclofenac%20epolamine","diclofenac%20potassium","diclofenac%20sodium"],"PubChem":["24424557"],"TG-GATEs":["19"],"Wikipedia":["Diclofenac"],"drugbank":["DB00586"],"chEBI":["47381"]},"childChemblIds":["CHEMBL1201180","CHEMBL3350449","CHEMBL1034","CHEMBL1200804"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_1001139","EFO_1000752","EFO_0004274","MONDO_0002959","EFO_0003964","EFO_0003103","EFO_0009560","EFO_0000544","EFO_1001366","EFO_1000786","EFO_0009582","EFO_1000720","EFO_0004616","EFO_1000652","HP_0003419","HP_0012532","EFO_1001466","EFO_0010072","EFO_0002496","EFO_0000546","MP_0001914","MP_0001845","GO_0007568","HP_0003326","HP_0003401","EFO_0009260","MONDO_0100096","HP_0030833","HP_0100607","MONDO_0002258","EFO_1001434","HP_0004418","EFO_0002970","MONDO_0003005","HP_0002373","EFO_0000278","MONDO_0007254","MONDO_0001370","MONDO_0001187","HP_0002829","MONDO_0005277","EFO_1001216","MONDO_0002050","MONDO_0005129","EFO_0004272","EFO_0004193","HP_0100749","EFO_0009321","EFO_0005752","EFO_0000616","MONDO_0021440","EFO_0000685","EFO_0000545","EFO_0009816","HP_0001945","EFO_0003958","EFO_0003898","EFO_0000313","EFO_0003843","EFO_0005755","HP_0002315","EFO_1001412","EFO_0009454","HP_0030839","EFO_0003827","EFO_0000649","EFO_0005611","MONDO_0005178"],"count":68},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and has 15 approved and 31 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL149082","canonicalSmiles":"NCCCS(=O)(=O)O","inchiKey":"SNKZJIOFVMKAOJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRAMIPROSATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-aminopropane sulfonic acid","Acamprosate related compound a","NC-758","NSC-77071","Tramiprosate"],"crossReferences":{"PubChem":["8139961","90340792"],"Wikipedia":["Homotaurine"],"drugbank":["DB06527"],"chEBI":["1457"]},"childChemblIds":["CHEMBL1256473","CHEMBL1256024"],"linkedTargets":{"rows":["ENSG00000142192"],"count":1},"linkedDiseases":{"rows":["HP_0100543","EFO_0000712","MONDO_0004975"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1618","canonicalSmiles":"Cn1nnnc1SCC1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)[C@H](OC=O)c3ccccc3)[C@H]2SC1.[Na+]","inchiKey":"ICZOIXFFVKYXOM-YCLOEFEOSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFAMANDOLE NAFATE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201218","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mandol"],"synonyms":["106223","Cefamandole Nafate sodium","Cefamandole nafate","Cefamandole nafate sodium","Cephamandole nafate","NSC-299588"],"crossReferences":{"chEBI":["3481"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1978 and has 1 investigational indication."}
{"id":"CHEMBL1649931","canonicalSmiles":"CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1cccc(F)c1","inchiKey":"QETUKYDWZIRTEI-QUMGSSFMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-232798","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-232798","Pf-00232798","Pf-232798"],"crossReferences":{"drugbank":["DB14813"]},"linkedTargets":{"rows":["ENSG00000160791"],"count":1},"linkedDiseases":{"rows":["EFO_0000764"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1697841","canonicalSmiles":"CNC(C)CCC=C(C)C","inchiKey":"XVQUOJBERHHONY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOMETHEPTENE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Isometheptene","Isonyl","Octanil"],"crossReferences":{"drugbank":["DB06706"]},"childChemblIds":["CHEMBL4303692","CHEMBL1327133","CHEMBL2105026","CHEMBL2355839"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for gastrointestinal disease and migraine disorder."}
{"id":"CHEMBL1743050","drugType":"Antibody","blackBoxWarning":false,"name":"OLOKIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDP-6038","CDP6038","Olokizumab"],"linkedTargets":{"rows":["ENSG00000136244"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","MONDO_0100096","MONDO_0005178","EFO_0000384"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1796999","canonicalSmiles":"C1CC1","inchiKey":"LVZWSLJZHVFIQJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOPROPANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyclopropane","Trimethylene"],"crossReferences":{"Wikipedia":["Cyclopropane"],"drugbank":["DB13984"],"chEBI":["30365"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL18","canonicalSmiles":"CCOc1ccc2nc(S(N)(=O)=O)sc2c1","inchiKey":"OUZWUKMCLIBBOG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHOXZOLAMIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardrase","Ethamide"],"synonyms":["Ethoxzolamide","NSC-10679"],"crossReferences":{"PubChem":["144204399","170465083","56422188","855751"],"Wikipedia":["Ethoxzolamide"],"drugbank":["DB00311"],"chEBI":["101096"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL186007","canonicalSmiles":"Oc1ccccc1Br","inchiKey":"VADKRMSMGWJZCF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Bromo-Phenol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Bromo-Phenol","2-Bromophenol","O-Bromophenol"],"crossReferences":{"drugbank":["DB04586"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL188","canonicalSmiles":"Cc1c(C(=O)c2cccc3ccccc23)c2cccc3c2n1[C@H](CN1CCOCC1)CO3","inchiKey":"HQVHOQAKMCMIIM-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"WIN-552122","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["WIN-55212-2"],"crossReferences":{"PubChem":["124881900","26754855","26754856","50110805","50110806","90341664"],"Wikipedia":["WIN_55,212-2"],"drugbank":["DB13950"],"chEBI":["73295"]},"childChemblIds":["CHEMBL1222317"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1905872","canonicalSmiles":"CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)[O-].[Na+]","inchiKey":"APSBXTVYXVQYAB-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DOCUSATE SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1477036","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Audinorm","Clear ear","Colace","Correctol stool softener laxative","D-s-s","Dialose","Dioctyl","Docusol","Docusol 100","Doxinate","Dulcoease","Fletchers' enemette","Klyx","Modane soft","Molcer","Molofac","Norgalax","Soliwax","Waxsol"],"synonyms":["Adekacol ec 8600","Aerosol ot","Airrol ct-1","Butyl-cerumen","Comfolax","Coprola","Di-n-octyl sodium sulfosuccinate","Dicapryl sodium sulfosuccinate","Diethylhexyl sodium sulfosuccinate","Dioctyl disodium sulfosuccinate","Dioctyl sodium sulfosuccinate","Dioctyl sodium sulphosuccinate","Dioctylal","Diotilan","Disonate","Docusate sodium","Docusate sodium solution","Doxol","Dulcivac","E 480","E-480","E480","Empimin op70","Eurowet","Gemtex pa-70","Ins no.480","Ins-480","Jamylene","Mackanate dos-70","Molatoc","Monawet mo 65-150","NSC-760404","NSC-7779","Neocol sw 30","Nevax","Nikkol otp-75","Nissan rapisol a 30","Rapisol a 30","Regutol","Sanmorin ot 70n","Sodium di-n-octyl sulfosuccinate","Sodium dioctyl sulfosuccinate","Texapon dos","Triton gr-pg 70","Velmol"],"crossReferences":{"PubChem":["144205640","144207018","144208540","144210814","26757557"],"Wikipedia":["Dioctyl_sodium_sulfosuccinate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved indications."}
{"id":"CHEMBL191190","canonicalSmiles":"O=C1c2ccccc2C(=O)N1CCOC(=S)Nc1ccc(Br)cc1","inchiKey":"BDVAWAILQCYMQE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL191190","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08281"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1933350","canonicalSmiles":"CCC[C@H](c1ccc(C(=O)NCCC(=O)O)cc1)[C@H](c1ccc(Cl)cc1)c1c[nH]c2c(F)cc(C)cc12","inchiKey":"FYRJJCYFYLLOSC-LXFBAYGMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-3577","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-3577"],"crossReferences":{"drugbank":["DB14957"]},"linkedTargets":{"rows":["ENSG00000215644"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1947204","canonicalSmiles":"C=CC(=O)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1","inchiKey":"MVZGYPSXNDCANY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALLITINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALL-3","AST-1306","Allitinib","Als 1306","Ast 1306","Ast-1306","Ast1306"],"childChemblIds":["CHEMBL4779286"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000141736"],"count":2},"linkedDiseases":{"rows":["MONDO_0008903"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL197669","canonicalSmiles":"CCCCc1nc(N)c2nc(-n3nccn3)n(C)c2n1","inchiKey":"CYYQMAWUIRPCNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ST1535","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ST-1535","St1535"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103736","canonicalSmiles":"CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.O.O.[Ca+2]","inchiKey":"LZPBLUATTGKZBH-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":true,"name":"FENOPROFEN CALCIUM","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1297","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fenoprofen calcium","Nalfon"],"synonyms":["69323","Fenoprofen calcium","Fenopron","Fepron","Feprona","Nalgesic"],"crossReferences":{"DailyMed":["fenoprofen%20calcium"],"chEBI":["5005"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0000685","MONDO_0005178"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for rheumatoid arthritis and osteoarthritis. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2103824","canonicalSmiles":"CC(=O)NCCOC(=O)[C@H](Oc1cccc(C(F)(F)F)c1)c1ccc(Cl)cc1","inchiKey":"BJBCSGQLZQGGIQ-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARHALOFENATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arhalofenate","CB-102","CB102","JNJ-39659100","M-102","M102","MBX-102"],"crossReferences":{"drugbank":["DB11811"]},"linkedTargets":{"rows":["ENSG00000197891","ENSG00000132170"],"count":2},"linkedDiseases":{"rows":["EFO_0004274","MONDO_0005148"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104393","canonicalSmiles":"O=c1c(I)cn(CC(O)CO)cc1I","inchiKey":"TZADDXVKYWMEHX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOPYDOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iopydol"],"crossReferences":{"drugbank":["DB13389"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104521","canonicalSmiles":"C[C@@H]1C[C@@H](OC(=O)c2cccnc2)CC(C)(C)C1","inchiKey":"GQSGZTBDVNUIQS-DGCLKSJQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CICLONICATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ciclonicate"],"crossReferences":{"drugbank":["DB13709"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104921","canonicalSmiles":"COc1ccc(NS(=O)(=O)c2ccc(NC(c3c(C)n(C)n(-c4ccccc4)c3=O)S(=O)(=O)O)cc2)nn1","inchiKey":"BGLHAKAJGYLSOX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAMAZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulfamazone"],"crossReferences":{"drugbank":["DB13556"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105499","canonicalSmiles":"Cc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1","inchiKey":"DZQVFHSCSRACSX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAPERIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BT-325","Isosulfamerazine","Sulfaperin"],"crossReferences":{"PubChem":["170466624"],"drugbank":["DB13320"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105687","canonicalSmiles":"CCCN[C@@H]1CCc2nc(N)sc2C1.Cl.Cl.O","inchiKey":"APVQOOKHDZVJEX-LSBIWMFESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXPRAMIPEXOLE DIHYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL249420","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dexpramipexole dihydrochloride","Dexpramipexole dihydrochloride monohydrate","KNS-760704","KNS-760704 ANHYDROUS","Pramipexole related compound d","SND 919CL2X","SND-919CL2X","SND-919CL2X MONOHYDRATE"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2105737","canonicalSmiles":"Cc1c(C(=O)Nc2ccc(N3C[C@H](C)O[C@H](C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1","inchiKey":"VZZJRYRQSPEMTK-CALCHBBNSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SONIDEGIB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Erismodegib","LDE 225","LDE-225","LDE225","NVP-LDE 225","NVP-LDE-225","NVP-LDE225","Sonidegib"],"crossReferences":{"DailyMed":["sonidegib%20phosphate"],"drugbank":["DB09143"]},"childChemblIds":["CHEMBL3137317"],"linkedTargets":{"rows":["ENSG00000128602"],"count":1},"linkedDiseases":{"rows":["MONDO_0013730","EFO_0000616","EFO_0002618","EFO_0003869","MONDO_0040677","MONDO_0008170","MONDO_0007254","MONDO_0005341","MONDO_0007576","EFO_0002939","MONDO_0008315","EFO_0000565","EFO_0001421","EFO_0001378","EFO_0004193"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for basal cell carcinoma and neoplasm and has 13 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2106220","canonicalSmiles":"CCC(=O)N(CC(C)N(C)CCc1ccccc1)c1ccccc1","inchiKey":"RXTHKWVSXOIHJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIAMPROMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acscn-9615","Diampromid","Diampromide","IDS-ND-005"],"crossReferences":{"drugbank":["DB01502"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107212","canonicalSmiles":"CN(CC(O)CO)C(=O)c1c(I)c(NC(=O)C(CO)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I","inchiKey":"YLPBXIKWXNRACS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOBITRIDOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iobitridol"],"crossReferences":{"drugbank":["DB12407"],"chEBI":["31701"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2107375","canonicalSmiles":"Cl.N=C(N)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1","inchiKey":"PIGYMBULXKLTCJ-UHSSARMYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TARIBAVIRIN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2111108","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Viramidine"],"synonyms":["Taribavirin hcl","Taribavirin hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2107962","drugType":"Unknown","blackBoxWarning":false,"name":"POLIOVIRUS VACCINE INACTIVATED","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Poliomyelitis vaccine","Poliovirus vaccine inactivated"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2109217","drugType":"Unknown","blackBoxWarning":false,"name":"PERFLUTREN PROTEIN-TYPE A MICROSPHERES","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Perflutren protein-type a microspheres"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109444","drugType":"Antibody","blackBoxWarning":false,"name":"AD-159","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AD-159"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109457","drugType":"Antibody","blackBoxWarning":false,"name":"LIGELIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ligelizumab","QGE-031","QGE031"],"linkedTargets":{"rows":["ENSG00000211891"],"count":1},"linkedDiseases":{"rows":["EFO_0005531","EFO_0007425","MONDO_0005271","MONDO_0004979","EFO_0000274","MONDO_0004784","EFO_1001881","EFO_0007187"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109528","drugType":"Antibody","blackBoxWarning":false,"name":"FASINUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fasinumab","REGN-475","REGN475","SAR-164877","SAR164877"],"linkedTargets":{"rows":["ENSG00000134259"],"count":1},"linkedDiseases":{"rows":["HP_0002027","EFO_1000786","EFO_0004616","HP_0003419","HP_0003418","MONDO_0005178","HP_0011868"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2109589","drugType":"Antibody","blackBoxWarning":false,"name":"L19TNFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L19TNFA","L19tnfa"],"linkedTargets":{"rows":["ENSG00000115414"],"count":1},"linkedDiseases":{"rows":["EFO_1001968","EFO_1001951"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110596","canonicalSmiles":"C=CCN1Cc2ccccc2-c2ccccc2C1","inchiKey":"NYGHGTMKALXFIA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZAPETINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azapeptine","Azapetine"],"crossReferences":{"drugbank":["DB13727"]},"childChemblIds":["CHEMBL2103986"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110636","canonicalSmiles":"CCCC(=O)Nc1c(I)cc(I)c(/C=C(\\CC)C(=O)O)c1I","inchiKey":"CWRBDUIQDIHWJZ-SOFGYWHQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUNAMIODYL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bunamiodyl"],"crossReferences":{"drugbank":["DB04814"]},"childChemblIds":["CHEMBL2104558"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2111186","canonicalSmiles":"C=Cc1c(C)c2cc3nc(c(CC(=O)N[C@@H](CC(=O)O)C(=O)O)c4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CC)c(C)c4C(=O)O)[C@@H](CCC(=O)O)[C@@H]3C","inchiKey":"VSEIDZLLWQQJGK-WSUYNKMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALAPORFIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Talaporfin"],"crossReferences":{"drugbank":["DB11812"]},"childChemblIds":["CHEMBL2107806"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2152999","canonicalSmiles":"Cc1c(C)c2c(c(C)c1OCC(=O)O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2","inchiKey":"LCFWOFKPFDWYLR-CEFNRUSXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":".ALPHA.-TOCOPHERYLOXYACETIC ACID","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.-tea",".alpha.-tocopheryloxyacetic acid","Alpha-tea","Alpha-tocopheryloxyacetic acid"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2153191","canonicalSmiles":"CCCSc1nc(N2CCC[C@@H](CC(=O)O)C2)ccc1C(=O)NC1CCCCC1","inchiKey":"NCDZABJPWMBMIQ-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-4017","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-4017","AZD4017","Azd 4017","Azd-4017"],"crossReferences":{"drugbank":["DB14875"]},"linkedTargets":{"rows":["ENSG00000117594"],"count":1},"linkedDiseases":{"rows":["EFO_1001069","EFO_1001132","EFO_1001110","EFO_0001073","MONDO_0005148"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL219341","canonicalSmiles":"O=c1[nH]c(=O)c2nn[nH]c2[nH]1","inchiKey":"KVGVQTOQSNJTJI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"8-Azaxanthine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["8-Azaxanthine"],"crossReferences":{"drugbank":["DB01875"],"chEBI":["40850"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2205230","canonicalSmiles":"CCc1cc2c(c(OCC(F)(F)F)c(C(=O)NC3CCN(C(=O)CO)CC3)n2C)c(=O)n1CC(=O)c1ccccc1","inchiKey":"ZADWXQMNNVICKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-441","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tak-441"],"linkedTargets":{"rows":["ENSG00000128602"],"count":1},"linkedDiseases":{"rows":["EFO_0004193"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2448612","canonicalSmiles":"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.O=C(O)C(O)C(O)C(=O)O","inchiKey":"CJMJLDQKTOJACI-SEUSHGJOSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ERGOTAMINE TARTRATE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL442","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cafergot","Ergomar","Ergostat","Femergin","Gynergen","Lingraine","Medihaler ergotamine","Migril","Wigrettes"],"synonyms":["Ergotamine bitartrate","Ergotamine d-tartrate","Ergotamine tartrate","Ergotamini tartras","Gotamine tartrate","NSC-41869"],"crossReferences":{"DailyMed":["ergotamine%20tartrate"]},"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000179546","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":7},"linkedDiseases":{"rows":["MONDO_0005277","HP_0002315"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1948 and is indicated for headache and migraine disorder. This drug has a black box warning from the FDA."}
{"id":"CHEMBL254193","canonicalSmiles":"N/N=c1/cc2c(n[nH]1)CCN(C(=O)c1ccccc1)C2","inchiKey":"ALAXZYHFVBSJKZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENDRALAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Endralazine"],"crossReferences":{"Wikipedia":["Endralazine"],"drugbank":["DB13435"]},"childChemblIds":["CHEMBL1980706"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL254520","canonicalSmiles":"Cc1cc(C)cc(C(=O)N(NC(=O)c2ccc3c(c2C)OCCO3)C(C)(C)C)c1","inchiKey":"JGJACZABNQGPMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL254520","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07929"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL266195","canonicalSmiles":"C=CCc1ccccc1OCC(O)CNC(C)C","inchiKey":"PAZJSJFMUHDSTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALPRENOLOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alprenolol","NSC-759561"],"crossReferences":{"PubChem":["104171111","124879296","144203635","170465812","26752306","50105225","50105226","90340777"],"Wikipedia":["Alprenolol"],"drugbank":["DB00866"],"chEBI":["51211"]},"childChemblIds":["CHEMBL3249366","CHEMBL1256179"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL270527","canonicalSmiles":"O=C(C1CCN(c2ccncc2)CC1)N1CCN(S(=O)(=O)c2ccc3cc(Cl)ccc3c2)CC1","inchiKey":"ZLAKCKVFSRSENR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL270527","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01836"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL280527","canonicalSmiles":"CCNc1cccnc1N1CCN(C(=O)c2cc3cc(OC)ccc3[nH]2)CC1","inchiKey":"UCPOMLWZWRTIAA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATEVIRDINE MESYLATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atevirdine","Atevirdine mesilate","Atevirdine mesylate","Atevirdine methanesulfonate","U-87201","U-87201E"],"crossReferences":{"Wikipedia":["Atevirdine"],"drugbank":["DB12264"]},"childChemblIds":["CHEMBL7264"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL285347","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)[O-])=C(SC3Cn4cnc[n+]4C3)[C@H](C)[C@H]12","inchiKey":"MRMBZHPJVKCOMA-YJFSRANCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIAPENEM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Biapenem","CL 186,815","CL-186815","L-627","LJ C10,627","LJ-C10627","LJC-10627","Omegacin"],"crossReferences":{"PubChem":["144205733"],"Wikipedia":["Biapenem"],"drugbank":["DB13028"],"chEBI":["3089"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL289233","canonicalSmiles":"COc1ccc2[nH]c(I)c(CCNC(C)=O)c2c1","inchiKey":"FJDDSMSDZHURBJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOMELATONIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Iodomelatonin","Iodomelatonin"],"crossReferences":{"PubChem":["11111317","11113672","26751858"],"drugbank":["DB08190"]},"childChemblIds":["CHEMBL1788358"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL291157","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2ccc(-c3ccncc3)cc21","inchiKey":"XBPZXDSZHPDXQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROSOXACIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eradacin","Roxadyl"],"synonyms":["Acrosoxacin","Eracine","Eradacil","Eradicin","NSC-146617","Rosoxacin","WIN 35,213","WIN-35213","Winoxacin","Winuron"],"crossReferences":{"Wikipedia":["Rosoxacin"],"drugbank":["DB00817"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL3039498","canonicalSmiles":"CCc1nc2c(C)nc(C)cc2n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1","inchiKey":"HZVLFTCYCLXTGV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GRAPIPRANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["423","AAT-007","CJ 023423","CJ-023","CJ-023423","Cj-023,423","Grapiprant","MR-10A7","MR10A7","RQ-00000007","RQ-7"],"crossReferences":{"drugbank":["DB12836"]},"linkedTargets":{"rows":["ENSG00000171522"],"count":1},"linkedDiseases":{"rows":["EFO_0000305","EFO_0003060","MONDO_0005178","EFO_1001951"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3039553","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"APATORSEN SODIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apatorsen sodium","OGX-427"],"description":"Oligonucleotide drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3104237","canonicalSmiles":"CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CSSC[C@H](NC(=O)CN)C(=O)N[C@@H](CSSC[C@@H](C(N)=O)NC1=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2","inchiKey":"KJQOYUHYAZGPIZ-PIJHVLQJSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CHEMBL3104237","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB05724"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3126842","canonicalSmiles":"COc1ccc2c(c1)[C@@H]1C[C@]1(C(=O)N1C3CCC1CN(C)C3)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)N(C)C)cc21","inchiKey":"ZTTKEBYSXUCBSE-VSBZUFFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BECLABUVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-791325","Beclabuvir"],"childChemblIds":["CHEMBL3137325"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3137331","canonicalSmiles":"CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1","inchiKey":"FWLMVFUGMHIOAA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEFACTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Defactinib","PF-04554878","VS-6063","Vs-6063"],"crossReferences":{"drugbank":["DB12282"]},"childChemblIds":["CHEMBL3137305"],"linkedTargets":{"rows":["ENSG00000120899","ENSG00000169398"],"count":2},"linkedDiseases":{"rows":["EFO_0002618","EFO_1000044","EFO_1000616","EFO_0000770","MONDO_0008170","EFO_0002517","EFO_0001378","EFO_0003060","EFO_0000311","EFO_1001951"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL327579","canonicalSmiles":"CC(C)(C)OC(=O)Nc1cccnc1C(=O)Nc1nccs1","inchiKey":"QBMYJIFXSXKPFS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL327579","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07902"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3306803","canonicalSmiles":"CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12","inchiKey":"HOIIHACBCFLJET-SFTDATJTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUMATEPERONE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ITI 007","ITI-007","ITI-722","ITI007","Lumateperone"],"crossReferences":{"DailyMed":["lumateperone%20tosylate"],"drugbank":["DB06077"]},"childChemblIds":["CHEMBL3233142"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000149295","ENSG00000102468"],"count":3},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0000289","MONDO_0002009","MONDO_0004975"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for schizophrenia and has 4 investigational indications."}
{"id":"CHEMBL3545165","canonicalSmiles":"O=C1Nc2ccccc2C(c2ccccc2)N1C1CCN(Cc2cccc(OC(F)(F)F)c2)CC1","inchiKey":"IJUMFEAYOMCXAQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFACIFENACIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Afacifenacin","NS-986","Smp-986"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000180720","ENSG00000184984","ENSG00000133019","ENSG00000181072","ENSG00000168356","ENSG00000168539"],"count":7},"linkedDiseases":{"rows":["EFO_1000781"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545279","canonicalSmiles":"Cc1cc(Oc2ccc3nc(COc4ccc(CC5SC(=O)NC5=O)cc4)n(C)c3c2)cc(C)c1N.Cl.Cl","inchiKey":"WFIOHOJEIMQCEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EFATUTAZONE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3545280","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CS-7017","Efatutazone dihydrochloride","Efatutazone hydrochloride","Inolitazone dihydrochloride","RS5444"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3663929","canonicalSmiles":"C=CC(=O)N1CC[C@@H](Oc2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)c(C(N)=O)nc2CC)C1","inchiKey":"QKDCLUARMDUUKN-XMMPIXPASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAQUOTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-8273","ASP8273","Naquotinib"],"crossReferences":{"drugbank":["DB12036"]},"childChemblIds":["CHEMBL3707350"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003060"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL375655","canonicalSmiles":"Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"NYHBQMYGNKIUIF-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANOSINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Guanosine"],"crossReferences":{"PubChem":["26754281"],"Wikipedia":["Guanosine"],"drugbank":["DB02857"],"chEBI":["16750"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833373","drugType":"Antibody","blackBoxWarning":false,"name":"AVELUMAB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bavencio"],"synonyms":["Avelumab","MSB-0010682","MSB0010682","MSB0010718C","Msb-0010718c"],"crossReferences":{"DailyMed":["avelumab"]},"linkedTargets":{"rows":["ENSG00000120217"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000637","EFO_0000365","EFO_0000756","EFO_0000681","EFO_1000657","EFO_0005952","EFO_0000228","EFO_1001951","Orphanet_178","EFO_0000588","EFO_0000564","EFO_0000339","EFO_0000096","EFO_0000182","EFO_0008528","Orphanet_2495","MONDO_0018352","EFO_0002618","EFO_0005922","MONDO_0008170","EFO_0000349","EFO_0003017","EFO_1001973","MONDO_0004986","MONDO_0008315","EFO_1000576","EFO_0000574","EFO_0006544","EFO_0001378","MONDO_0100342","EFO_1001901","MONDO_0007254","EFO_0004252","MONDO_0021063","EFO_0002890","MONDO_0002087","EFO_0000305","EFO_0000231","MONDO_0001187","EFO_1001480","EFO_1000044","MONDO_0002158","EFO_0003968","MONDO_0002898","EFO_0000196","EFO_0000183","EFO_0000707","EFO_1000158","EFO_0000616","EFO_0006859","EFO_0000503","Orphanet_59305","EFO_0000403","EFO_0000222","MONDO_0007576","EFO_0003060","EFO_0000311","EFO_0003863","EFO_1001471","EFO_1000581","MONDO_0002529","MONDO_0002120","EFO_0002517","MONDO_0011962","EFO_0004142","EFO_0000702","MONDO_0018906","MONDO_0024880","EFO_0000519","EFO_0000181"],"count":71},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 4 approved and 57 investigational indications."}
{"id":"CHEMBL3931971","canonicalSmiles":"COC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(NS(=O)(=O)O)cc1)c1csc(-c2cccs2)n1","inchiKey":"KWJDHELCGJFUHW-SFTDATJTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAZUPROTAFIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AKB-9778","Razuprotafib"],"linkedTargets":{"rows":["ENSG00000127329"],"count":1},"linkedDiseases":{"rows":["EFO_1001157","EFO_0009321","EFO_0009760"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989985","drugType":"Enzyme","blackBoxWarning":false,"name":"RIBAXAMASE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["P3A","Ribaxamase","SYN-004"],"description":"Enzyme drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL404431","canonicalSmiles":"CC(C)(N)CNC(=O)C[C@H]1CC[C@]2(CC1)OO[C@]1(O2)C2CC3CC(C2)CC1C3","inchiKey":"VXYZBLXGCYNIHP-CAGINOIPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OZ277","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OZ-277","Oz277"],"childChemblIds":["CHEMBL570680"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL406734","canonicalSmiles":"COC(=O)[C@H](Cc1ccc(Br)cc1)NC(=O)CCCCCCC(=O)NO","inchiKey":"UPYGSQPRAHMDPD-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL406734","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08505"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL416755","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2cc3c(cc21)OCO3","inchiKey":"KYGZCKSPAKDVKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXOLINIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Utibid"],"synonyms":["Aqualinic","NSC-110364","Oxolinate","Oxolinic acid","W 4565","W-4565"],"crossReferences":{"PubChem":["104171206","11111565","11111566","144203767","144209985","26747409","26747410","50100298","50105701","50105702","85231164","855760","90340649"],"Wikipedia":["Oxolinic_acid"],"drugbank":["DB13627"],"chEBI":["138856"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4204794","canonicalSmiles":"Cn1cc(-c2cc3c(N4CCN(c5ncc([C@@](C)(N)c6ccc(F)cc6)cn5)CC4)ncnn3c2)cn1","inchiKey":"DWYRIWUZIJHQKQ-SANMLTNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVAPRITINIB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ayvakit"],"synonyms":["70C366","Avapritinib","BLU-285","C-366","X-720776","X720776"],"crossReferences":{"DailyMed":["avapritinib"],"drugbank":["DB15233"]},"linkedTargets":{"rows":["ENSG00000134853","ENSG00000157404"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0007359","Orphanet_44890","EFO_0000326","MONDO_0016586","EFO_0000311"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL4297239","drugType":"Cell","blackBoxWarning":false,"name":"DILANUBICEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dilanubicel","NLA-101","NLA101"],"description":"Cell drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297410","drugType":"Small molecule","blackBoxWarning":false,"name":"IT-139","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["It-139","KP-1339","NKP-1339","Nkp-1339"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297413","canonicalSmiles":"FC(F)(F)C(C(F)(F)F)(C(F)(F)F)C1(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C1(F)F","inchiKey":"VLTXBOGHSBHSAC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERFLUORO TERT-BUTYLCYCLOHEXANE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxycyte","Perfluoro t-butylcyclohexane","Perfluoro tert-butylcyclohexane"],"crossReferences":{"drugbank":["DB12477"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297625","canonicalSmiles":"CCc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc2c(c1)OCCO2","inchiKey":"XFJAMQQAAMJFGB-ZQGJOIPISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LICOGLIFLOZIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LIK-066","LIK066","Licogliflozin","Lik066"],"crossReferences":{"drugbank":["DB15048"]},"childChemblIds":["CHEMBL4762033"],"linkedTargets":{"rows":["ENSG00000140675","ENSG00000100170"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003095","MONDO_0005148","EFO_0001073","EFO_0000660"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297663","canonicalSmiles":"Cn1c(=O)c2c(ncn2CC(=O)O)n(C)c1=O.Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1","inchiKey":"IPUHJDQWESJTGD-PFWPSKEQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMBROXOL ACEFYLLINATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acebrophylline","Ambromucil","Ambroxol acefyllinate","Ambroxol theophyllinate","Ambroxol-theophylline-7-acetate","Broncomnes","Surfolase"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297813","drugType":"Unknown","blackBoxWarning":false,"name":"PRI-724","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S,S)-ICG-001","Foscenvivint","PRI-724","PRI724","Pri-724"],"linkedTargets":{"rows":["ENSG00000005339","ENSG00000168036"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000044","EFO_0000365","EFO_0000339","EFO_0000222"],"count":5},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297980","drugType":"Unknown","blackBoxWarning":false,"name":"HM-43239","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HM-43239","HM43239","Hm-43239","Hm43239"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298008","drugType":"Unknown","blackBoxWarning":false,"name":"LYMPHOCYTE ACTIVATION GENE 3 PROTEIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cd-223","Cd223","Lag-3","Lymphocyte activation gene 3 protein"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL431651","canonicalSmiles":"CCCOc1ccc2c(c1)[C@@H](c1ccc(OC)cc1OCCO)[C@H](C(=O)O)[C@H]2c1ccc2c(c1)OCO2","inchiKey":"GLCKXJLCYIJMRB-UPRLRBBYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENRASENTAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enrasentan","SB-217242","Sb-217242"],"crossReferences":{"drugbank":["DB06460"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL432162","canonicalSmiles":"Cc1nc(C)c2c(n1)N(Cc1ccc(-c3ccccc3-c3nn[nH]n3)cc1)C(=O)CC2","inchiKey":"ADXGNEYLLLSOAR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TASOSARTAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANA-756","Tasosartan","WAY-ANA-756"],"crossReferences":{"drugbank":["DB01349"]},"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL457526","canonicalSmiles":"N#Cc1ccc(COc2ccc3cc(S(=O)(=O)N[C@H](CCC(=O)O)C(=O)O)ccc3c2)c(F)c1","inchiKey":"IRJUSGUHNFMVCK-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL457526","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08112"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL457530","canonicalSmiles":"CN(C)C(=N)NCCC[C@H](N)C(=O)O","inchiKey":"YDGMGEXADBMOMJ-LURJTMIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL457530","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111070","90341201"],"Wikipedia":["Asymmetric_dimethylarginine"],"drugbank":["DB01686"],"chEBI":["17929"]},"childChemblIds":["CHEMBL1255836"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594341","drugType":"Antibody","blackBoxWarning":false,"name":"VIXARELIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["30C6 [N73D) IgG4P.agly/IgG1","BIIB-069","BIIB069","KPL-716","Kpl-716","Vixarelimab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4594454","canonicalSmiles":"C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12.Cl.O.O","inchiKey":"CMDJNMACGABCKQ-XVSRHIFFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIPASUDIL HYDROCHLORIDE DIHYDRATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3426621","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glanatec","K-115","K-115-R","Ripasudil hydrochloride dihydrate","Ripasudil hydrochloride hydrate"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4594502","drugType":"Unknown","blackBoxWarning":false,"name":"TAK-981","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Subasumstat","Sumoylation inhibitor tak-981","TAK-981","Tak-981"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4650286","canonicalSmiles":"Nc1nn2cc(F)cnc2c1C(=O)Nc1cncc(F)c1N1CCC(C(=O)N2CCN(C3COC3)CC2)CC1","inchiKey":"QAYHKBLKSXWOEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"M4344","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gartisertib","M 4344","M-4344","M4344","VX-803"],"linkedTargets":{"rows":["ENSG00000175054"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0008170","MONDO_0007254"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL46618","canonicalSmiles":"COC(=O)[C@H](Cc1cccc(C(=N)N)c1)[C@@H](C)NC(=O)c1ccc(-c2cc[n+]([O-])cc2)cc1","inchiKey":"PFGVNLZDWRZPJW-OPAMFIHVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OTAMIXABAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FXV-673","Fxv673","Otamixaban","RPR-130673","RPR130673","XRP-0673","XRP0673"],"crossReferences":{"Wikipedia":["Otamixaban"],"drugbank":["DB06635"]},"linkedTargets":{"rows":["ENSG00000126218"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0001645","EFO_0001421","EFO_0005672"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL490225","canonicalSmiles":"CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"QFAPUKLCALRPLH-UXXRCYHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL490225","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02451"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL492","canonicalSmiles":"CCCN(CC)C(CC)C(=O)Nc1c(C)cccc1C","inchiKey":"VTUSIVBDOCDNHS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETIDOCAINE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Duranest [as hydrochloride]"],"synonyms":["Etidocaine","W-19053","W-19053 [AS HYDROCHLORIDE]"],"crossReferences":{"PubChem":["144206521"],"Wikipedia":["Etidocaine"],"drugbank":["DB08987"],"chEBI":["4904"]},"childChemblIds":["CHEMBL1200597"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976."}
{"id":"CHEMBL49563","canonicalSmiles":"Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCCC(C)CCCC(C)C)O2","inchiKey":"GVJHHUAWPYXKBD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"alpha-TOCHOPHEROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["225144220","26749212","50107544"],"drugbank":["DB14476"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL497001","canonicalSmiles":"O=C1c2c(O)cccc2C([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c2cc(CO)cc(O)c21","inchiKey":"AFHJQYHRLPMKHU-CGISPIQUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALOIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alloin","Aloin","Aloin A","Aloins","Aloinum","Barbaloin"],"crossReferences":{"Wikipedia":["Aloin"],"drugbank":["DB15477"],"chEBI":["73222"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL500853","canonicalSmiles":"CCCCCCOC(C)c1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)O)[C@@H]3C","inchiKey":"PVXGCBZIVFCMJK-NMWXTPPCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HPPH","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hpph","Photochlor"],"crossReferences":{"drugbank":["DB15243"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL504802","canonicalSmiles":"O=C(O)C[C@H](NC(=O)CP(=O)(O)O)C(=O)O","inchiKey":"ZZKNRXZVGOYGJT-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sparfosic Acid"],"crossReferences":{"drugbank":["DB03459"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL506972","canonicalSmiles":"CCOC(=O)c1c(C)n[nH]c1C","inchiKey":"BCKARVLFIJPHQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL506972","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04271"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL514432","canonicalSmiles":"C[C@@H]1C(=O)O[C@H]2[C@H](O)[C@@]34[C@H]5C[C@@H](C(C)(C)C)[C@]36[C@@H](OC(=O)[C@@H]6O)O[C@@]4(C(=O)O5)[C@@]12O","inchiKey":"SQOJOAFXDQDRGF-MMQTXUMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GINKOLIDE B","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["49664977"],"drugbank":["DB06744"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL519374","canonicalSmiles":"CO[C@@]1(NC(=O)[C@H](C(=O)O)c2ccc(O)cc2)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CO[C@@H]21","inchiKey":"JWCSIUVGFCSJCK-LIUKBUMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL519374","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04342"]},"childChemblIds":["CHEMBL4303378"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL526","canonicalSmiles":"CC(C)c1cccc(C(C)C)c1O","inchiKey":"OLBCVFGFOZPWHH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPOFOL","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diprivan","Disoprivan","Propofol","Rapinovet"],"synonyms":["Disoprofol","Fresofol","ICI 35,868","ICI 35-868","ICI-35868","ICI35,868","Lipuro","NSC-5105","Phenol, 2,6-bis(1-methylethyl)","Propofol"],"crossReferences":{"DailyMed":["propofol"],"PubChem":["104171149","11111121","11111122","124879991","144203685","144208569","144213542","170464994","17389856","26747380","47193694","50105615","90341256"],"Wikipedia":["Propofol"],"drugbank":["DB00818"],"chEBI":["44915"]},"childChemblIds":["CHEMBL356637","CHEMBL154232"],"linkedTargets":{"rows":["ENSG00000109158","ENSG00000145863","ENSG00000011677","ENSG00000187730","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000022355","ENSG00000102287","ENSG00000182256","ENSG00000094755","ENSG00000268089","ENSG00000163285","ENSG00000113327","ENSG00000186297","ENSG00000163288"],"count":16},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003777","HP_0000989","EFO_0007486","EFO_0000275","MONDO_0002009","HP_0001298","EFO_0003855","EFO_0005773","EFO_0004698","EFO_1001951","EFO_0000565","HP_0100543","EFO_0003931","EFO_0000544","EFO_0003870","MONDO_0008903","EFO_0003884","EFO_0003877","EFO_1001250","EFO_0008526","EFO_0002618","HP_0002093","EFO_0001074","EFO_0009447","EFO_0002687","EFO_0005323","HP_0001919","EFO_0000662","EFO_0000546","EFO_0001422","HP_0100806","MP_0001845","MONDO_0100096","MONDO_0001208","HP_0002045","EFO_0004888","HP_0001336","EFO_0005109","EFO_0009659","HP_0031273","EFO_0003767","EFO_0005251","MONDO_0018373","EFO_0003086","MONDO_0005090","EFO_0006834","EFO_1001905","EFO_1001454","MONDO_0021117","EFO_0009267","EFO_1000637","EFO_1001311","EFO_1002048","MONDO_0024355","EFO_0002950","MONDO_0005277","MONDO_0002050","EFO_1001801","HP_0030834","MONDO_0005180","MONDO_0005129","HP_0002017","EFO_0000712","EFO_0003839","EFO_0009854","MONDO_0007079","EFO_0003917","EFO_0007490","EFO_0000616","EFO_0000694","EFO_0005774","EFO_0009551","HP_0000486","EFO_0004210","EFO_0004329","EFO_0003832","EFO_0002623","EFO_0001645","EFO_0005207","HP_0011110","MONDO_0007576","EFO_0000313","HP_0003418","MONDO_0004379","EFO_0001073","EFO_0003843","EFO_0009549","EFO_0002615","EFO_0000311","HP_0000713","EFO_0000537","EFO_0001072","EFO_0000713","EFO_0003890","EFO_0004273","MONDO_0002367","EFO_0005611","MONDO_0043510","EFO_0003918","EFO_0004259","MONDO_0005178","EFO_0003833"],"count":103},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 47 investigational indications."}
{"id":"CHEMBL547","canonicalSmiles":"CC1=C(/C=C/C(C)=C/C=C/C(C)=C\\C(=O)O)C(C)(C)CCC1","inchiKey":"SHGAZHPCJJPHSC-XFYACQKRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ISOTRETINOIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Absorica","Absorica ld","Accutane","Amnesteem","Claravis","Isotrex","Myorisan","Roaccutane","Sotret","Zenatane"],"synonyms":["13 Cis-Retinoic Acid","13-cis-retinoic acid","Isotretinoin","NSC-758156","PAT-001","RO 4-3780","RO-4-3780","RO-43780","Retinoic acid 13-cis-form","Retinoic acid, 13-cis-","Vitamin a acid, 13-cis"],"crossReferences":{"DailyMed":["isotretinoin"],"PubChem":["144207291","26747659","26753641","26753642","26753643","26753644","47193696","50106981","90341473"],"Wikipedia":["Isotretinoin"],"drugbank":["DB00982"],"chEBI":["6067"]},"linkedTargets":{"rows":["ENSG00000131759","ENSG00000077092","ENSG00000172819"],"count":3},"linkedDiseases":{"rows":["EFO_1000910","MONDO_0000873","EFO_1000764","MONDO_0019269","EFO_0000464","EFO_0000681","MONDO_0007254","EFO_1001465","EFO_1001129","EFO_1000690","EFO_0000632","EFO_0000565","EFO_0000309","EFO_0000339","EFO_0000544","MONDO_0002974","MONDO_0003268","EFO_0000279","MONDO_0008903","EFO_0000330","EFO_0002499","EFO_0000183","EFO_1000158","EFO_0000198","EFO_0000616","EFO_0006859","EFO_0000180","EFO_0000403","EFO_1001006","MONDO_0000870","EFO_0002939","EFO_0000222","EFO_0000502","EFO_1000309","EFO_0004236","EFO_0007512","EFO_0003894","EFO_0000224","EFO_0000621","MONDO_0008315","EFO_0002496","Orphanet_3389","EFO_0002501","EFO_1000760","MONDO_0100096","MONDO_0004975","MONDO_0002367","EFO_1001051","EFO_0001378","EFO_0003833","EFO_0000519","MONDO_0021640"],"count":52},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for acne and has 45 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL570533","canonicalSmiles":"Cc1cccc(-c2nc(Nc3ccncc3)c3ccccc3n2)n1","inchiKey":"JONFDFIXMPXTRH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL570533","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07267"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL580","canonicalSmiles":"O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O","inchiKey":"DIWRORZWFLOCLC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LORAZEPAM","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abbloraz","Ativan","Loraz","Lorazepam","Lorazepam intensol","Lorazepam preservative free","Loreev xr","Temesta"],"synonyms":["Lorazepam","Lorazepam civ","NSC-289758","WY-4036"],"crossReferences":{"DailyMed":["lorazepam"],"PubChem":["144205222","29215381"],"Wikipedia":["Lorazepam"],"drugbank":["DB00186"]},"linkedTargets":{"rows":["ENSG00000182256","ENSG00000022355","ENSG00000011677","ENSG00000163285","ENSG00000151834","ENSG00000113327","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0002610","EFO_0004777","EFO_0011061","EFO_1000924","MONDO_0002009","HP_0000726","HP_0001268","EFO_0009267","EFO_1000800","EFO_1000690","HP_0002018","EFO_0000474","MONDO_0002050","EFO_0003761","HP_0002013","EFO_0004701","MONDO_0007079","EFO_0004242","EFO_0005230","EFO_0008526","EFO_0006788","EFO_0000677","EFO_0009692","HP_0001250","MONDO_0004900","EFO_0003843","EFO_1001146","HP_0000713","EFO_1001892","EFO_0003890","MONDO_0004975","EFO_0005411"],"count":33},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 5 approved and 20 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL659","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2","inchiKey":"ASUTZQLVASHGKV-JDFRZJQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GALANTAMINE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acumor xl","Consion xl","Elmino xl","Galsya xl","Galzemic xl","Gatalin xl","Gazylan xl","Lotprosin xl","Luventa xl","Reminyl","Reminyl xl","Zeebral xl"],"synonyms":["(-)-galantamine","(-)-galanthamine","Galantamine","Galanthamine","NSC-100058","Razadyne"],"crossReferences":{"DailyMed":["galantamine%20hydrobromide"],"PubChem":["104171341","144204358","26751839"],"Wikipedia":["Galantamine"],"drugbank":["DB00674"],"chEBI":["42944"]},"childChemblIds":["CHEMBL4467191","CHEMBL3099484","CHEMBL1555"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","Orphanet_282","EFO_0002610","EFO_0004718","EFO_0004280","HP_0000726","EFO_1001905","EFO_0005252","EFO_0003768","EFO_1001461","HP_0100543","EFO_0000289","MONDO_0002050","EFO_0000712","EFO_0005230","EFO_0003888","EFO_0000677","EFO_0003758","EFO_0006792","EFO_0001073","EFO_0000195","EFO_0001072","EFO_0000713","Orphanet_79292","EFO_0004895","EFO_0000764","MONDO_0004975","EFO_0005411"],"count":28},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for alzheimer disease and dementia and has 19 investigational indications."}
{"id":"CHEMBL70972","canonicalSmiles":"CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O","inchiKey":"ZBVKEHDGYSLCCC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERATRODAST","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-73001","AA-2414","ABBOTT 73001","ABBOTT-73001","ABT-001","Bronica","NSC-759640","Seratrodast"],"crossReferences":{"PubChem":["144206327","170465940","50125893"],"drugbank":["DB06739"]},"linkedTargets":{"rows":["ENSG00000006638"],"count":1},"linkedDiseases":{"rows":["HP_0006536"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL851","canonicalSmiles":"O=C(O)CCc1ccccc1","inchiKey":"XMIIGOLPHOKFCH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYL PROPIONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenyl propionic acid"],"crossReferences":{"PubChem":["144212646"],"drugbank":["DB02024"],"chEBI":["28631"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL871","canonicalSmiles":"CC(O)(P(=O)(O)O)P(=O)(O)O","inchiKey":"DBVJJBKOTRCVKF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETIDRONIC ACID","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Didronel","Etidronate","Etidronic acid","M05BA01","NSC-227995"],"crossReferences":{"PubChem":["144207615","29215269","93576729"],"Wikipedia":["Etidronic_acid"],"drugbank":["DB01077"],"chEBI":["4907"]},"childChemblIds":["CHEMBL1874205","CHEMBL1201042"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1977 and is indicated for bone disease."}
